Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)

XSAT:ISAB Revenue

Inhalation Sciences Sweden AB had revenue of 4.15M SEK in the quarter ending March 31, 2026, with 412.61% growth. This brings the company's revenue in the last twelve months to 6.38M, down -19.62% year-over-year. In the year 2025, Inhalation Sciences Sweden AB had annual revenue of 3.04M, down -72.47%.

• Revenue (ttm): 6.38M
• Revenue Growth: -19.62%
• P/S Ratio: 1.81
• Revenue / Employee: 1.28M
• Employees: 5
• Market Cap: 11.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.04M	-8.01M	-72.47%
Dec 31, 2024	11.05M	-6.46M	-36.89%
Dec 31, 2023	17.50M	5.31M	43.55%
Dec 31, 2022	12.19M	2.77M	29.42%
Dec 31, 2021	9.42M	-715.00K	-7.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 24, 2026

Data Sources Report a data error